Stem Cell Research News ($)
Stem Cell Business News ($)
Subscription Page
It's  

 
NEW! 2012 Guide to Stem Cell Research Companies

Complete listing of global companies performing stem cell research... PLUS stem cell research suppliers AND for-profit cord blood banks!

Click for more information 
Stem Cell Lab World

For qualified stem cell scientists and lab administrators...

Click for more information
 
 

 

Welcome to

Stem Cell Business News

Biweekly; 8-16 pages

PDF only;  nonprofit,
for-profit, individual rates

 


Founded in 2002, Stem Cell Business News provides in-depth news of public and private companies (U.S. and global) involved in stem cell research. Includes basic and clinical research findings, legislation and regulation, experimental therapies, finance and funding, patents, strategic alliances, and much more. 

Whether you're a competitor, supplier, investor, analyst, etc. -- if your professional life requires reliable, independent intelligence on stem cell research companies, you should subscribe today to Stem Cell Business News!

 

 

Stem Cell Business News keeps you updated on stem cell company news AND each issue takes a close look at public stem cell company financial statements and other documents to find out what’s really happening: beneath the surface … behind the headlines and the press releases.

The only independent biweekly report that covers stem cell companies in depth -- including including public company SEC 10-K and 10-Q analysis, IPO plans, research and clinical trial news, finance and funding, mergers and acquisitions, etc.

 

You'll make wiser, better informed investment decisions by having at your fingertips detailed information on products in development, preclinical and clinical trials, financial problems, merger and acquisition activity, research and marketing collaborations, significant risks, management changes, etc.

We do not forecast the market. We do not recommend buys, sells, or holds. We simply read, interview, analyze, and report, so that potential investors can make intelligent, and hopefully profitable, decisions about their stem cell company portfolio. Available in PDF format only.

View a sample issue: Click here. NOTE: To view this PDF file you will need Adobe Acrobat Reader. To download and install this free view software, click on the Adobe icon.

Subscription options:

  • For-profit rate: $345.00. PDF via e-mail. This is the basic rate for public and private companies. Save $100 when you order both Stem Cell Research News and Stem Cell Business News at the corporate rate.
     
  • Nonprofit rate: $269.00. PDF. Special rate for schools, hospitals, government agencies, nonprofit organizations, etc.
     
  • Individual rate: $99.00. PDF. For students, patients, and patients' families. NOT for employees of any institution  performing stem cell research or doing business of any kind for or with an organization performing stem cell research.
     

To choose one of these options, click here. Your subscription order will be processed securely via Fleapay and the BrainTree Payment Solutions.

Subscribe to both Stem Cell Research News AND Stem Cell Business News at the same time at the corporate rate! Save $100 on both subscriptions together. Click here to order.

   

 
 


 

Copyright © 2003 -  2014 by DataTrends Publications, Inc. All rights reserved.